Australia markets closed

TG Therapeutics, Inc. (TGTX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
16.01-0.41 (-2.47%)
As of 03:47PM EDT. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts7788
Avg. Estimate-0.05-0.01-0.020.59
Low estimate-0.09-0.08-0.250.11
High estimate-0.020.030.451.02
Year ago EPS-0.340.730.09-0.02
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts7788
Avg. Estimate65.89M77.98M308.72M472.37M
Low estimate64.54M74.9M291.2M364.42M
High estimate68.1M80M391.53M528M
Year ago sales17.45M46.56M233.66M308.72M
Sales growth (year/est)277.60%67.50%32.10%53.00%
Earnings history29/06/202329/09/202330/12/202330/03/2024
Est. EPS-0.250.12-0.1-0.04
Actual EPS-0.340.73-0.1-0.07
Difference-0.090.610-0.03
Surprise %-36.00%508.30%0.00%-75.00%
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Current estimate-0.05-0.01-0.020.59
7 days ago-0.06-0.05-0.090.53
30 days ago-0.07-0.05-0.110.48
60 days ago-0.06-0.03-0.090.55
90 days ago-0.07-0.02-0.120.43
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Up last 7 days5665
Up last 30 days5665
Down last 7 daysN/AN/AN/AN/A
Down last 30 days2123
Growth estimatesTGTXIndustrySector(s)S&P 500
Current qtr.85.30%N/AN/AN/A
Next qtr.-101.40%N/AN/AN/A
Current year-122.20%N/AN/AN/A
Next year3,050.00%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A